These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36380561)

  • 1. Fontan-associated liver disease after heart transplant.
    Griffiths ER; Lambert LM; Ou Z; Shaaban A; Rezvani M; Carlo WF; Schumacher KR; DiPaola F; O'Connor MJ; Nandi D; Zangwill S; McCulloch MA; Friedland-Little JM; West SC; Lee TM; Alejos JC; Chen S; Molina KM
    Pediatr Transplant; 2023 Mar; 27(2):e14435. PubMed ID: 36380561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function.
    Simpson KE; Esmaeeli A; Khanna G; White F; Turnmelle Y; Eghtesady P; Boston U; Canter CE
    J Heart Lung Transplant; 2014 Feb; 33(2):170-7. PubMed ID: 24365764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous outcomes of liver disease after heart transplantation for a failed Fontan procedure.
    Ybarra AM; Khanna G; Turmelle YP; Stoll J; Castleberry CD; Scheel J; Ballweg JA; Ameduri R; Kimberling M; Makil E; Birnbaum BF; Exil V; Canter CE; Simpson KE
    Pediatr Transplant; 2021 Dec; 25(8):e14094. PubMed ID: 34296503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does liver biopsy accurately measure fibrosis in Fontan-associated liver disease? A comparison of liver biopsy pre-combined heart and liver transplant and liver explant post-transplant.
    Vaikunth SS; Higgins JP; Concepcion W; Haeffele C; Wright GE; Chen S; Lui GK; Daugherty T
    Clin Transplant; 2020 Dec; 34(12):e14120. PubMed ID: 33053213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplantation and Post-Transplantation Liver Disease Assessment in Adolescents Undergoing Isolated Heart Transplantation for Fontan Failure.
    Rodriguez DS; Mao C; Mahle WT; Kanter KR; Alazraki A; Braithwaite K; Rytting H; Caltharp S; Magliocca JF; Romero R
    J Pediatr; 2021 Feb; 229():78-85.e2. PubMed ID: 32976893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
    Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
    Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive biomarkers of Fontan-associated liver disease.
    Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
    JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associated Factors of Liver Disease After Fontan Operation in Relation to Ultrasound Liver Elastography.
    Sethasathien S; Silvilairat S; Sittiwangkul R; Makonkawkeyoon K; Pongprot Y
    Pediatr Cardiol; 2020 Dec; 41(8):1639-1644. PubMed ID: 32740670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes.
    Wu FM; Jonas MM; Opotowsky AR; Harmon A; Raza R; Ukomadu C; Landzberg MJ; Singh MN; Valente AM; Egidy Assenza G; Perez-Atayde AR
    J Heart Lung Transplant; 2015 Jul; 34(7):883-91. PubMed ID: 25863891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of combined heart‒liver vs heart-only transplantation in pediatric and young adult Fontan recipients.
    Sganga D; Hollander SA; Vaikunth S; Haeffele C; Bensen R; Navaratnam M; McDonald N; Profita E; Maeda K; Concepcion W; Bernstein D; Chen S
    J Heart Lung Transplant; 2021 Apr; 40(4):298-306. PubMed ID: 33485775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fontan-associated protein-losing enteropathy and post‒heart transplant outcomes: A multicenter study.
    Schumacher KR; Yu S; Butts R; Castleberry C; Chen S; Edens E; Godown J; Johnson J; Kemna M; Lin K; Lowery R; Simpson K; West S; Wilmot I; Gossett JG
    J Heart Lung Transplant; 2019 Jan; 38(1):17-25. PubMed ID: 30391195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fontan-associated liver disease: Implications for heart transplantation.
    Greenway SC; Crossland DS; Hudson M; Martin SR; Myers RP; Prieur T; Hasan A; Kirk R
    J Heart Lung Transplant; 2016 Jan; 35(1):26-33. PubMed ID: 26586487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Kim MH; Nguyen A; Lo M; Kumar SR; Bucuvalas J; Glynn EF; Hoffman MA; Fischer R; Emamaullee J
    Transplantation; 2021 Jan; 105(1):18-22. PubMed ID: 32639398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance elastography of the liver in patients status-post fontan procedure: feasibility and preliminary results.
    Serai SD; Wallihan DB; Venkatesh SK; Ehman RL; Campbell KM; Sticka J; Marino BS; Podberesky DJ
    Congenit Heart Dis; 2014; 9(1):7-14. PubMed ID: 24134059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
    Amdani S; Simpson KE; Thrush P; Shih R; Simmonds J; Knecht K; Mogul DB; Hurley K; Koehl D; Cantor R; Naftel D; Kirklin JK; Daly KP
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1462-1473.e12. PubMed ID: 33745714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Provider Management Practices and Attitudes Toward Referral for Advanced Heart Failure Therapies in Fontan Patients Across North America.
    Sadat-Hossieny S; Karamlou T; Marino BS; Gossett JG; Schumacher K; Patel A; Worley S; Alsaied T; Amdani S
    J Card Fail; 2022 Apr; 28(4):576-587. PubMed ID: 34991953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive assessment of liver abnormalities in pediatric Fontan patients.
    De Bruyne R; Vandekerckhove K; Van Overschelde H; Hendricx F; Vande Walle C; De Groote K; Panzer J; De Wolf D; Van Biervliet S; Bové T; François K
    Eur J Pediatr; 2022 Jan; 181(1):159-169. PubMed ID: 34231051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
    Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
    Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver abnormalities and post-transplant survival in pediatric Fontan patients.
    Hofferberth SC; Singh TP; Bastardi H; Blume ED; Fynn-Thompson F
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 29105236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.